These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 17316407)

  • 1. Drug transporters in the epileptic brain.
    Löscher W
    Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of drug resistance.
    Löscher W
    Epileptic Disord; 2005 Sep; 7 Suppl 1():S3-9. PubMed ID: 16120487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Redeker S; Aronica E; Wadman WJ; Marchi N; Vezzani A; Gorter JA
    Epilepsia; 2006 Apr; 47(4):672-80. PubMed ID: 16650133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.
    van Vliet EA; Zibell G; Pekcec A; Schlichtiger J; Edelbroek PM; Holtman L; Aronica E; Gorter JA; Potschka H
    Neuropharmacology; 2010 Feb; 58(2):404-12. PubMed ID: 19786037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport.
    Potschka H
    Adv Drug Deliv Rev; 2012 Jul; 64(10):943-52. PubMed ID: 22210135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
    Kwan P; Brodie MJ
    Epilepsia; 2005 Feb; 46(2):224-35. PubMed ID: 15679503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasticity of antiepileptic drug targets.
    Beck H
    Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy.
    Brandt C; Bethmann K; Gastens AM; Löscher W
    Neurobiol Dis; 2006 Oct; 24(1):202-11. PubMed ID: 16928449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures.
    Volk HA; Löscher W
    Brain; 2005 Jun; 128(Pt 6):1358-68. PubMed ID: 15716304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OC144-093, a novel P glycoprotein inhibitor for the enhancement of anti-epileptic therapy.
    Newman MJ; Dixon R; Toyonaga B
    Novartis Found Symp; 2002; 243():213-26; discussion 226-30, 231-5. PubMed ID: 11990779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.
    Potschka H
    Pharmacogenomics; 2010 Oct; 11(10):1427-38. PubMed ID: 21047204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Voskuyl RA; Redeker S; Aronica E; Wadman WJ; Gorter JA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):141-7. PubMed ID: 17392402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
    Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
    Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling to P-glycoprotein-A new therapeutic target to treat drug-resistant epilepsy?
    Hartz AM; Notenboom S; Bauer B
    Drug News Perspect; 2009 Sep; 22(7):393-7. PubMed ID: 19890496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
    Bankstahl JP; Löscher W
    Epilepsy Res; 2008 Nov; 82(1):70-85. PubMed ID: 18760905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy.
    Rambeck B; Jürgens UH; May TW; Pannek HW; Behne F; Ebner A; Gorji A; Straub H; Speckmann EJ; Pohlmann-Eden B; Löscher W
    Epilepsia; 2006 Apr; 47(4):681-94. PubMed ID: 16650134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.
    Schmidt D; Löscher W
    Epilepsia; 2005 Jun; 46(6):858-77. PubMed ID: 15946327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug resistance in epilepsy].
    Czuczwar P; Kaczmarczyk K; Wierzchowska-Cioch E; Łuszczki JJ; Czuczwar SJ
    Przegl Lek; 2009; 66(11):963-6. PubMed ID: 20297639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Several major antiepileptic drugs are substrates for human P-glycoprotein.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of drug resistance in epilepsy].
    Lasoń W
    Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.